Ratings Elanco Animal Health Incorporated

Equities

ELAN

US28414H1032

Real-time Estimate Cboe BZX 02:11:25 2024-07-15 pm EDT 5-day change 1st Jan Change
13.38 USD -3.08% Intraday chart for Elanco Animal Health Incorporated -3.98% -10.17%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • Low profitability weakens the company.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
-10.17% 6.82B
B-
+35.00% 3.96B
B-
+2.78% 3.29B
B-
+20.10% 1.76B -
-3.22% 1.27B -
-39.28% 1.03B
B
-43.09% 963M
C-
-19.34% 846M -
-36.21% 840M -
-13.14% 811M
D+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ELAN Stock
  4. Ratings Elanco Animal Health Incorporated